BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 14729104)

  • 21. Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells.
    Yoshizumi M; Kogame T; Suzaki Y; Fujita Y; Kyaw M; Kirima K; Ishizawa K; Tsuchiya K; Kagami S; Tamaki T
    Br J Pharmacol; 2002 Aug; 136(7):1023-32. PubMed ID: 12145102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of protein kinase B by the A(1)-adenosine receptor in DDT(1)MF-2 cells.
    Germack R; Dickenson JM
    Br J Pharmacol; 2000 Jun; 130(4):867-74. PubMed ID: 10864894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells.
    Nguyen A; Chen P; Cai H
    FEBS Lett; 2004 Aug; 572(1-3):307-13. PubMed ID: 15304367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation.
    Hung CC; Ichimura T; Stevens JL; Bonventre JV
    J Biol Chem; 2003 Aug; 278(31):29317-26. PubMed ID: 12738790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylpyridinium (MPP(+))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells.
    Halvorsen EM; Dennis J; Keeney P; Sturgill TW; Tuttle JB; Bennett JB
    Brain Res; 2002 Oct; 952(1):98-110. PubMed ID: 12363409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species.
    Yoshizumi M; Abe J; Haendeler J; Huang Q; Berk BC
    J Biol Chem; 2000 Apr; 275(16):11706-12. PubMed ID: 10766791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the p38 and p42/p44 mitogen-activated protein kinase families by the histamine H(1) receptor in DDT(1)MF-2 cells.
    Robinson AJ; Dickenson JM
    Br J Pharmacol; 2001 Aug; 133(8):1378-86. PubMed ID: 11498525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p38(MAPK) and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y.
    Filomeni G; Piccirillo S; Rotilio G; Ciriolo MR
    Biochem Pharmacol; 2012 May; 83(10):1349-57. PubMed ID: 22342995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration.
    Tsai HR; Yang LM; Tsai WJ; Chiou WF
    Eur J Pharmacol; 2004 Sep; 498(1-3):45-52. PubMed ID: 15363974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin inhibits extracellular regulated kinase 1/2 phosphorylation in a phosphatidylinositol 3-kinase (PI3) kinase-dependent manner in Neuro2a cells.
    van der Heide LP; Hoekman MF; Biessels GJ; Gispen WH
    J Neurochem; 2003 Jul; 86(1):86-91. PubMed ID: 12807428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones.
    Perkinton MS; Ip JK; Wood GL; Crossthwaite AJ; Williams RJ
    J Neurochem; 2002 Jan; 80(2):239-54. PubMed ID: 11902114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
    Chiou WF; Tsai HR; Yang LM; Tsai WJ
    Int Immunopharmacol; 2004 Oct; 4(10-11):1329-41. PubMed ID: 15313431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1/2, but not Akt, activation in renal cells.
    Zhuang S; Schnellmann RG
    Am J Physiol Renal Physiol; 2004 May; 286(5):F858-65. PubMed ID: 15075181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p62 protects SH-SY5Y neuroblastoma cells against H2O2-induced injury through the PDK1/Akt pathway.
    Heo SR; Han AM; Kwon YK; Joung I
    Neurosci Lett; 2009 Jan; 450(1):45-50. PubMed ID: 19010391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human adipose tissue conditioned media from lean subjects is protective against H2O2 induced neurotoxicity in human SH-SY5Y neuronal cells.
    Wan Z; Mah D; Simtchouk S; Kluftinger A; Little JP
    Int J Mol Sci; 2015 Jan; 16(1):1221-31. PubMed ID: 25569096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
    Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM
    Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent.
    Miloso M; Villa D; Crimi M; Galbiati S; Donzelli E; Nicolini G; Tredici G
    J Neurosci Res; 2004 Jan; 75(2):241-252. PubMed ID: 14705145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts.
    Kefaloyianni E; Gaitanaki C; Beis I
    Cell Signal; 2006 Dec; 18(12):2238-51. PubMed ID: 16806820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
    Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
    Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.